Live feed
Filing
SC 13G/A
SC 13G/A0001683168-20-000338·BRISTOL INVESTMENT FUND LTD
Schedule 13G ownership disclosure
GT Biopharma, Inc.
Security class unavailable · CUSIP: 36254L100
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.4700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-20-000338
- Form type
- SC 13G/A
- Filer
- BRISTOL INVESTMENT FUND LTD
- CIK
- CIK 1174866
- Filed
- Feb 04, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership